title: Targeted cytotoxic cells as a novel form of cancer immunotherapy.
authors.affiliation: Immunology Branch, National Cancer Institute, Bethesda, MD 20892.
authors.forename: D M
authors.initials: DM
authors.lastname: Segal
authors.forename: M A
authors.initials: MA
authors.lastname: Garrido
authors.forename: P
authors.initials: P
authors.lastname: Perez
authors.forename: J A
authors.initials: JA
authors.lastname: Titus
authors.forename: D A
authors.initials: DA
authors.lastname: Winkler
authors.forename: D B
authors.initials: DB
authors.lastname: Ring
authors.forename: A
authors.initials: A
authors.lastname: Kaubisch
authors.forename: J R
authors.initials: JR
authors.lastname: Wunderlich
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D051379:Mice; D008819:Mice, Nude; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal